Wiki source code of Neurodiagnoses

Version 21.1 by manuelmenendez on 2025/01/28 00:30

Show last authors
1 (% class="jumbotron" %)
2 (((
3 (% class="container" %)
4 (((
5 = //A new tridimensional diagnostic framework for neurodegenerative diseases// =
6
7 This project is focused on developing a novel nosological and diagnostic framework for neurodegenerative diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.
8 We aim to create a structured, interpretable, and scalable diagnostic tool.
9 )))
10 )))
11
12 (% class="row" %)
13 (((
14 (% class="col-xs-12 col-sm-8" %)
15 (((
16 = What is this about and what can I find here? =
17
18 == **Overview** ==
19
20 The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDD) are classified by focusing on:
21
22 * **Axis 1**: Etiology (genetic or other causes of diseases).
23 * **Axis 2**: Molecular Markers (biomarkers).
24 * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
25
26 [[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
27
28
29 This methodology enables:
30
31 * Greater precision in diagnosis.
32 * Integration of incomplete datasets using AI-driven probabilistic modeling.
33 * Stratification of patients for personalized treatment.
34
35 == **Diagnostic Axes** ==
36
37 * (((
38 **Axis 1: Etiology**
39
40 * //Description//: Focuses on genetic and sporadic causes, identifying risk factors and potential triggers.
41 * //Examples//: APOE ε4 as a genetic risk factor, or cardiovascular health affecting NDD progression.
42 * //Tests//: Genetic testing, lifestyle and cardiovascular screening.
43 )))
44 * (((
45 **Axis 2: Molecular Markers**
46
47 * //Description//: Analyzes primary (amyloid-beta, tau) and secondary biomarkers (NFL, GFAP) for tracking disease progression.
48 * //Examples//: CSF amyloid-beta concentrations to confirm Alzheimer’s pathology.
49 * //Tests//: Blood/CSF biomarkers, PET imaging (Tau-PET, Amyloid-PET).
50 )))
51 * (((
52 **Axis 3: Neuroanatomoclinical**
53
54 * //Description//: Links clinical symptoms to neuroanatomical changes, such as atrophy or functional impairments.
55 * //Examples//: Hippocampal atrophy correlating with memory deficits.
56 * //Tests//: MRI volumetrics, FDG-PET, neuropsychological evaluations.
57 )))
58
59 == **Applications** ==
60
61 This system enhances:
62
63 * **Research**: By stratifying patients, reduces cohort heterogeneity in clinical trials.
64 * **Clinical Practice**: Provides dynamic diagnostic annotations with timestamps for longitudinal tracking.
65
66 == Who has access? ==
67
68 We welcome contributions from the global community. Let’s build the future of neurological diagnostics together!
69
70 == How to Contribute ==
71
72 * Access the `/docs` folder for guidelines.
73 * Use `/code` for the latest AI pipelines.
74 * Share feedback and ideas in the wiki discussion pages.
75
76 == Key Objectives ==
77
78 * Develop interpretable AI models for diagnosis and progression tracking.
79 * Integrate data from Human Phenotype Ontology (HPO), Gene Ontology (GO), and other biomedical resources.
80 * Foster collaboration among neuroscientists, AI researchers, and clinicians.
81 )))
82
83
84 (% class="col-xs-12 col-sm-4" %)
85 (((
86 {{box title="**Contents**"}}
87 {{toc/}}
88 {{/box}}
89
90 == Main contents ==
91
92 * `/docs`: Documentation and contribution guidelines.
93 * `/code`: Machine learning pipelines and scripts.
94 * `/data`: Sample datasets for testing.
95 * `/outputs`: Generated models, visualizations, and reports.
96 * [[Methodology>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Methodology/]]
97 * [[Results>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Results/]]
98 )))
99 )))